Federico II University: Clinical Trials

465 trials sponsored by Federico II University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

253 completed, 123 unknown, 49 recruiting, 16 not yet recruiting. 173 Not applicable, 42 Phase 4, 36 Phase 3, 28 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable173Completed 96, Unknown 48, Recruiting 11, Not yet recruiting 6, Active not recruiting 5, Enrolling by invitation 3, Terminated 3, Withdrawn 1
Phase 442Completed 31, Unknown 7, Recruiting 3, Not yet recruiting 1
Phase 336Completed 20, Unknown 9, Withdrawn 5, Recruiting 1, Terminated 1
Phase 228Completed 16, Unknown 7, Recruiting 2, Suspended 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow Federico II University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0)
Right Ventricular Dysfunction, Cardiopulmonary Diseases
Not yet recruitingIRCCS SYNLAB SDN20002027-01-012026-10-01
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Medical Reading, AI assisted Medical reading - Kidney Cancers, Prostate Cancer
Not yet recruitingAristotle University Of Thessaloniki502026-10-152026-10-22
Dynamic Postoperative Trends for Early Detection of Complications After Gastrointestinal Surgery
blood sampling - Oncologic Disease, Urgent Surgery
Not yet recruitingAzienda Ospedaliero Universitaria Maggiore della Carita15002026-09-012026-04-03
Neurolyser XR for the Treatment of Sacroiliitis
Patients treated with high intensity focused ultrasound - Sacroiliitis, Low Back Pain
Not applicableNot yet recruitingFederico II University302026-07-012026-06-16
Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer
Breast Cancer, Triple Negative Breast Cancer (TNBC)
Not yet recruitingFederico II University1862026-07-012026-06-23
The Impact of Postbiotic Supplementation on Tolerability and Physiological/Metabolic Parameters
Postbiotic Supplement, Placebo - Gastrointestinal Health
Not applicableActive not recruitingFederico II University222026-06-222026-10-23
Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)
Shared Decision Making (SDM) Support Program - Breast Cancer, HER2 Negative Breast Cancer
Not applicableNot yet recruitingFederico II University1202026-06-012026-05-11
Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health (SUGAR-SYN BC3O)
Sugar-Based Synbiotic Product, Inulin-Containing Sugar Product - Overweight Adults
Not applicableEnrolling by invitationFederico II University202026-05-042026-09-08
TRacheostomy in DElphi for iNTensive Care' (TRiDENT)
Delphi Consensus Process - Delphi Process, Delphi Study
Not yet recruitingUniversita degli Studi di Genova402026-05-012026-05-04
Validation of the Italian SCHFI v.8 and the CC-SCHFI v.3
Administration of the Italian version of the SCHFI and the CC-SCHFI, plus other self-reported ouctome measures - Heart Failure
Not yet recruitingCentro Cardiologico Monzino10002026-05-012026-05-27
Tinnitus and Treatment With umPEA-LUT
PEA-LUT 2 sachet day, Placebo, umPEALUT + Rutin + 5 hTp - Tinnitus, Neuroinflammation
Not applicableNot yet recruitingUniversity of Campania Luigi Vanvitelli1002026-04-202026-02-06
Fall Prevention in Older Adults in an Italian Cohort
Khymeia - Fall Risk, Fall Prevention, Fall Risk
Not yet recruitingFederico II University502026-02-202026-02-27
Use of Continuous Glucose Monitoring to Evaluate Postprandial Response to Raw Cornstarch Supplementation in Adult Glycogen Storage Disease Type I
Glycogen Storage Disease Type I
RecruitingFederico II University82026-02-052026-06-12
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
Ranolazine - STEMI (ST Elevation MI)
Phase 2 / Phase 3RecruitingFederico II University1002026-02-012026-03-11
Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy
Rice formula (New formula based on hydrolysed rice proteins), Placebo formula - IgE-Mediated Cow Milk Allergy
Not applicableRecruitingHealth and Happiness Research Limited292026-01-232026-09-09
Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study
Ropeginterferon alfa-2b (BESREMiĀ®) - Polycytemia Vera
Not yet recruitingFederico II University1502026-01-102025-12-15
Autoimmune Hyperthyroidism in Prepubertal Children
restrospective observational study - Autoimmune Hyperthyroidism, Children
Enrolling by invitationIRCCS Ospedale San Raffaele1002026-01-012026-04-22
Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel
Women will receive the application of an anti-adhesion gel at the end of the myomectomy procedure - Myoma;Uterus, Adhesion; Uterus, Internal
Not applicableNot yet recruitingFederico II University622025-12-092025-12-12
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
Bempedoic acid - Hypercholesterolemia
RecruitingFederico II University15002025-11-042026-01-29
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
semaglutide, Standard Treatment (Guideline-Based) - T2DM (Type 2 Diabetes Mellitus)
Phase 4RecruitingFederico II University802025-09-082026-01-02

Showing 20 of 465. Sign in to see all of them.

Conditions studied

Obesity (22)  ·  Heart Failure (19)  ·  Milk Hypersensitivity (19)  ·  Premature Birth (17)  ·  Acute Coronary Syndrome (12)  ·  Diabetes Mellitus, Type 2 (11)  ·  Metabolic Syndrome (10)  ·  Dwarfism, Pituitary (9)  ·  Breast Neoplasms (8)  ·  Diabetes Mellitus, Type 1 (8)  ·  Hypersensitivity (8)  ·  Overweight (8)  ·  Coronary Artery Disease (7)  ·  Food Hypersensitivity (7)  ·  Insulin Resistance (7)

Interventions

Diet, Mediterranean (7)  ·  Growth Hormone (6)  ·  Cerclage, Cervical (4)  ·  Exercise (4)  ·  Human Growth Hormone (4)  ·  Data Collection (3)  ·  Dietary Supplements (3)  ·  Hyaluronic Acid (3)  ·  Ranibizumab (3)  ·  Synbiotics (3)  ·  lanreotide (3)  ·  policosanol (3)  ·  Berberine (2)  ·  Blood Specimen Collection (2)  ·  Butyrates (2)

Countries

Italy (398)  ·  Spain (6)  ·  Germany (5)  ·  United Kingdom (5)  ·  Belgium (4)  ·  Netherlands (4)  ·  United States (3)  ·  Canada (2)  ·  Greece (2)  ·  Hungary (2)  ·  Norway (2)  ·  Russia (2)  ·  Croatia (1)  ·  Egypt (1)  ·  France (1)

Top investigators

Gilda Cennamo (15)  ·  Bruno Trimarco, MD (6)  ·  Annamaria Colao, MD, PhD (5)  ·  Giovanni Esposito, MD, PhD (5)  ·  Alessandro Filla, MD (4)  ·  Roberto Berni Canani, MD, PhD (4)  ·  Annamaria AL Colao, Prof. (3)  ·  Annamaria Colao, MD (3)  ·  Serafino Fazio, MD (3)  ·  Alfredo Guarino, MD (2)  ·  Amanda Roman, MD (2)  ·  Annamaria Colao (2)  ·  Annamaria Colao, Prof (2)

Results publications

PMID 17259801, PMID 17984237, PMID 10690849, PMID 12641619, PMID 14769829, PMID 15613435, PMID 15827109, PMID 16449332, PMID 16487447, PMID 16537687, PMID 18445662, PMID 34091663, PMID 42142332, PMID 9808008, PMID 10022400, PMID 10199767, PMID 10199774, PMID 10207464, PMID 10372687, PMID 10469005, PMID 10507588, PMID 10517918, PMID 10573522, PMID 10763759, PMID 10792333, PMID 10811995, PMID 10823456, PMID 10950010, PMID 10984283, PMID 10999798, PMID 11207626, PMID 11273062, PMID 11344175, PMID 11397887, PMID 11531927, PMID 11739428, PMID 11788630, PMID 11880025, PMID 11889170, PMID 12066229, PMID 12198662, PMID 12238249, PMID 12390688, PMID 12531880, PMID 12540801, PMID 12591191, PMID 12759473, PMID 12843148, PMID 12924350, PMID 12934784

NIH funding

2025 (2), 2009 (1), 2016 (1), 2017 (1)